Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand

BACKGROUND: This study aims to determine the maximum price at which HIV vaccination is cost-effective in the Thai healthcare setting. It also aims to identify the relative importance of vaccine characteristics and risk behavior changes among vaccine recipients to determine how they affect this cost-...

Descripción completa

Detalles Bibliográficos
Autores principales: Leelahavarong, Pattara, Teerawattananon, Yot, Werayingyong, Pitsaphun, Akaleephan, Chutima, Premsri, Nakorn, Namwat, Chawetsan, Peerapatanapokin, Wiwat, Tangcharoensathien, Viroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224093/
https://www.ncbi.nlm.nih.gov/pubmed/21729309
http://dx.doi.org/10.1186/1471-2458-11-534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224093/
https://www.ncbi.nlm.nih.gov/pubmed/21729309
http://dx.doi.org/10.1186/1471-2458-11-534

Ejemplares similares